String Biosciences News Today

Broken String Biosciences ("Broken String"), a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the appointment of Gavin Burns, PhD, as Vice President...

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the expansion of its senior leadership team.

Broken String Biosciences today announced that it has closed a $15 million Series A investment round.

to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology. Key suggestions from the report: The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, ...

Image by Viacheslav Iakobchuk - Adobe Stock Illumina has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the United States and the United Kingdom. Unlocking the power of the human genome is a feat that no one organization can fully accomplish on its own. Thats why, back in 2014, Illumina created the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. ...

San Diego-based life sciences equipment giant Illumina said today that it has made investments in nine new genomics companies, as part of the companys startup accelerator, the Illumina Accelerator.